Ontology highlight
ABSTRACT: Introduction
Immune checkpoint inhibitors (ICI), e.g., targeting programmed cell death protein 1-ligand 1 (PD-L1) or its receptor PD-1, have markedly improved the therapy of many cancers but so far failed in pancreatic ductal adenocarcinoma (PDAC). Macrophages represent one of the most abundant immune cell populations within the tumor microenvironment (TME) of PDAC being able to either support or restrain tumor progression depending on their phenotype. To better understand treatment failure of PD-L1/PD-1 inhibitors in PDAC, this study examined PD-L1 expression in the context of a dynamic TME in PDAC with a particular focus on the impact of macrophages.Methods
Formalin-fixed and paraffin embedded tissue samples of primary PDAC tissues and corresponding liver metastases were
SUBMITTER: Daunke T
PROVIDER: S-EPMC10337136 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature